Invention Grant
- Patent Title: Imidazo bicyclic iminium compounds as antitumor agents
-
Application No.: US14409683Application Date: 2013-06-19
-
Publication No.: US09611276B2Publication Date: 2017-04-04
- Inventor: James Chen , Tomoyo Sakata Kato , Alison Evelynn Ondrus
- Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
- Applicant Address: US CA Stanford
- Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
- Current Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
- Current Assignee Address: US CA Stanford
- Agency: Heslin Rothenberg Farley & Mesiti, P.C.
- Agent Philip Hansen
- International Application: PCT/US2013/046560 WO 20130619
- International Announcement: WO2013/192301 WO 20131227
- Main IPC: C07D515/04
- IPC: C07D515/04 ; C07D513/04 ; A61K31/437 ; C07D471/04 ; C07D487/04 ; A61K31/4188 ; A61K31/429 ; A61K31/5383 ; A61K31/55 ; C07D498/04
Abstract:
Compounds of formula I: are disclosed. The compounds are inhibitors of Hedgehog pathway activation and are useful in treating solid tumors. An example of such a compound is:
Public/Granted literature
- US20150191489A1 IMIDAZO BICYCLIC IMMINIUM COMPOUNDS AS ANTITUMOR AGENTS Public/Granted day:2015-07-09
Information query
